Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-02

Clinical Trial Update: Evaluating Dashboard-Integrated Pharmacist-Led Education on Improving Sacubitril/Valsartan Adherence in Heart Failure (PharmD ASSIST HFrEF) [NA]

View source ↗

Summary

This clinical trial protocol evaluates dashboard-integrated, pharmacist-led education aimed at improving adherence to sacubitril/valsartan in heart failure with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entresto (sacubitril/valsartan)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Heart Failure With Reduced Ejection Fraction (HFrEF), Sacubitril/Valsartan | NA | Status: NOT_YET_RECRUITING